作者：
Jens,Schittenhelm [1]
;
Lukas,Ziegler [2]
;
Jan,Sperveslage [2]
;
Michel,Mittelbronn [3]
;
David,Capper [4]
;
Isabel,Burghardt [5]
;
Antti,Poso [6]
;
Saskia,Biskup [7]
;
Marco,Skardelly [8]
;
Ghazaleh,Tabatabai [9]
作者单位：
Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
[1]
Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
[2]
Department of Pathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
[3]
Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster, Germany.
[4]
Luxembourg Center of Neuropathology (LCNP), Dudelange, Luxembourg.
[5]
Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
[6]
National Center of Pathology (NCP), Laboratoire National de Santé (LNS), Dudelange, Luxembourg.
[7]
Department of Oncology (DONC), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
[8]
Edinger Institute (Neurological Institute), University of Frankfurt, Frankfurt, Germany.
[9]
Institute of Neuropathology, Berlin Institute of Health, Berlin, Germany.
[10]
Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
[11]
Department of Neurology & Interdisciplinary Neurooncology, University Hospital Tübingen, Hertie-Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tuebingen, Germany.
[12]
Department of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
[13]
CeGaT GmbH and Praxis für Humangenetik Tuebingen, Tuebingen, Germany.
[14]
Department of Neurosurgery, University Hospital of Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
[15]
Center for Personalized Medicine, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
[16]
German Consortium for Translational Cancer Research (DKTK), DKFZ partner site Tuebingen, Tuebingen, Germany.
[17]
DOI
10.1093/nop/npaa075
PMID
33898054
发布时间
2022-04-22
换一批
换一批
